DILH
ALXN

Dai-ichi Life Holdings’s Alexion Pharmaceuticals ALXN Stock Holding History

Dai-ichi Life Holdings’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-34,123
Closed -$4.18M – 499
2016
Q3 		$4.18M Sell
34,123
-7
-0% -$901 0.13% 181
2016
Q2 		$3.98M Sell
34,130
-911
-3% -$129K 0.12% 188
2016
Q1 		$4.88M Sell
35,041
-228
-0.6% -$33.5K 0.15% 152
2015
Q4 		$6.73M Sell
35,269
-674
-2% -$118K 0.21% 110
2015
Q3 		$5.62M Buy
35,943
+7,617
+27% +$1.39M 0.17% 133
2015
Q2 		$5.12M Sell
28,326
-10,068
-26% -$1.74M 0.15% 147
2015
Q1 		$6.65M Buy
38,394
+467
+1% +$84.5K 0.19% 124
2014
Q4 		$7.02M Buy
37,927
+6,839
+22% +$1.27M 0.2% 108
2014
Q3 		$5.16M Buy
31,088
+14,485
+87% +$2.38M 0.15% 139
2014
Q2 		$2.59M Buy
16,603
+95
+0.6% +$15K 0.08% 263
2014
Q1 		$2.51M Sell
16,508
-17,215
-51% -$2.74M 0.08% 268
2013
Q4 		$4.49M Sell
33,723
-674
-2% -$80.9K 0.14% 156
2013
Q3 		$4M Sell
34,397
-1,170
-3% -$128K 0.14% 150
2013
Q2 		$3.28M Buy
+35,567
New +$3.43M 0.12% 182

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Dai-ichi Life Holdings's ALXN Position: Q4 2016 in Review

Dai-ichi Life Holdings sold out of Alexion Pharmaceuticals (ALXN) in Q4 2016, closing a stake of 34,123 shares — an estimated $4.18M sold.

Dai-ichi Life Holdings first reported a position in ALXN in Q2 2013 and held it in 14 quarters. The position peaked at $7.02M in Q4 2014. 548 funds tracked by Wall St. Rank hold ALXN as of Q4 2016.

  • Dai-ichi Life Holdings reported no remaining Alexion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 34,123 Alexion Pharmaceuticals shares in Q4 2016, an estimated $4.18M.
  • Dai-ichi Life Holdings first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Dai-ichi Life Holdings's Alexion Pharmaceuticals position peaked at $7.02M in Q4 2014.
  • 548 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.